Vault-13

TYNDALL CAPITAL PARTNERS L P

NEW YORK, NY · CIK 1219314 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$451.6k reported value +9.6% vs Q1 2025
1positions
100.0%in top 10
0 new 0 added 1 reduced 0 sold out vs Q1 2025

This manager withheld holdings under SEC confidential treatment in both Q2 2025 and Q1 2025, so new and sold-out positions can't be determined.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CYCLERION THERAPEUTICS INC COM COM 155,187 $451.6k100.00% 100.00% ReducedShares held: Q3 2024 164.8k, Q4 2024 164.8k, Q1 2025 164.8k, Q2 2025 155.2k -9.6k -9,590 -5.8%